the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

No ‘concerning’ issues in department power abuse allegations, says Fahmi

PUTRAJAYA: An internal investigation by the Communications Ministry has found no ‘concerning’ issues related to allegations of power abuse in one of its departments, its minister Fahmi Fadzil said.

Speaking at a press conference today, Fahmi, who is also the spokesperson for the Unity Government, said he had been informed about the issue and it has been brought to the attention of ministry secretary-general Datuk Mohamad Fauzi Md Isa.

“An internal investigation has been conducted, and as of today, we have not found any concerning or troubling issues. As a policy, we do not entertain poison pen letters. The matter (poison pen letter) does not involve the current director-general but rather the former director-general of the department,” Fahmi said.

Yesterday, a Telegram channel, ‘Edisi Siasat’ uploaded a copy of an anonymous letter that contained allegations of abuse of power at the Information Department (JaPen) and which implicated several individuals allegedly involved in the misconduct.

The letter was addressed to Malaysian Anti-Corruption Commission (MACC) Chief Commissioner Tan Sri Azam Baki, with copies sent to several senior government officials, including Chief Secretary to the Government Tan Sri Mohd Zuki Ali, Public Service Department (PSD) director-general Datuk Seri Wan Ahmad Dahlan Abdul Aziz and Mohamad Fauzi.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings